Wagstaff, J., Mason, M. D., Clarke, N. W., James, N. D., Dearnaley, D. P., Spears, M. R., . . . Sydes, M. R. (2017). Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. Journal of Clinical Oncology, 35(14), pp. 1530-1541. doi:10.1200/JCO.2016.69.0677

Wagstaff, John, et al. "Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial." Journal of Clinical Oncology 35, no. 14 (2017): 1530-1541.

Wagstaff, John, et al. "Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial." Journal of Clinical Oncology 35.14 (2017): 1530-1541.